MT MPJE study materials
MT MPJE study resources

MT MPJE flashcards

MT MPJE · Build recall with a focused review session.

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Montana Board of Pharmacy
State agency that licenses pharmacists, technicians, and pharmacy outlets and enforces the Montana Pharmacy Practice Act through rules, inspections, and disciplinary action.
Pharmacist-in-charge duties
The PIC is responsible for the pharmacy's compliance with drug laws, recordkeeping, security, and supervision of personnel; changes in PIC must be reported to the Board as required by rule.
Technician registration
Montana requires pharmacy technicians to register with the Board; certified technicians may perform expanded duties defined in rule, but pharmacists retain final verification responsibility.
CQI program requirement
Montana pharmacies must maintain a documented continuous quality improvement program that reviews dispensing errors and quality-related events and retains records for Board review.
Montana PDMP reporting
Dispensers report controlled substance prescriptions to the Montana Prescription Drug Registry on the schedule set by rule; pharmacists may query the registry when clinically appropriate.
Immunization by pharmacists
Montana pharmacists may administer vaccines under a protocol or prescription, with required training, CPR certification, documentation, and reporting to the state immunization information system.
Collaborative drug therapy
Montana permits pharmacists to participate in collaborative practice under a written protocol with a prescriber, allowing defined drug therapy management and monitoring activities.
Generic substitution
A pharmacist may substitute a therapeutically equivalent generic product unless the prescriber prohibits substitution; the patient must be informed and records maintained per rule.
Pharmacy license per location
Each pharmacy location must hold a current Board license; relocation, ownership change, or closure triggers notification or new licensure requirements under Montana rules.
Patient counseling duty
Pharmacists must offer counseling on new and changed prescriptions, covering directions, precautions, and interactions, unless the patient declines or an exception applies.
Prescription transfer rules
Prescriptions may be transferred between pharmacies as permitted by law; controlled substance transfers are limited, and Schedule II prescriptions generally cannot be refilled after transfer.
Record retention
Montana pharmacies must retain prescription and dispensing records for the period set by Board rule and make them available for inspection on request.
Unprofessional conduct
Grounds for discipline include dispensing without a valid prescription, impaired practice, falsifying records, and violating Board rules or drug laws.
Schedule II refills
Schedule II prescriptions may not be refilled; a new prescription is required, and emergency oral orders must be followed by a written prescription within 7 days.
Schedule III-V refills
Prescriptions for Schedule III through V drugs may be refilled up to 5 times within 6 months of the issue date unless the prescriber directs otherwise.
DEA Form 106
Report used to document theft or significant loss of controlled substances; it must be submitted to the DEA field office within one business day of discovery.
Biennial inventory
DEA requires a complete inventory of controlled substances every two years, with Schedule II counted separately and records retained for at least two years.
EPCS requirements
Electronic controlled substance prescriptions require DEA-compliant software, identity proofing, and two-factor authentication; pharmacists must verify compliance before dispensing.
DEA registration renewal
DEA registrations are valid for three years and must be renewed before expiration; dispensing without a current registration violates federal law.
Partial fill Schedule II
A Schedule II prescription may be partially filled when the pharmacist cannot supply the full quantity; the remainder must be dispensed within 30 days.
HIPAA minimum necessary
Covered entities must limit protected health information disclosures to the minimum necessary for the purpose, except for treatment disclosures and certain required reporting.
DSCSA verification
The Drug Supply Chain Security Act requires trading partners to verify suspect or illegitimate product and maintain transaction information, statements, and histories.
Prescription validity
A valid prescription must be issued for a legitimate medical purpose by a prescriber acting in the usual course of practice; pharmacists must resolve red flags before dispensing.
Corresponding responsibility
Pharmacists share responsibility with prescribers to ensure controlled substance prescriptions are valid and issued for a legitimate medical purpose.
Controlled substance records
Records of receipt, dispensing, and disposal of controlled substances must be maintained for two years and kept separate or readily retrievable for DEA inspection.
Schedule I status
Schedule I substances have high abuse potential and no accepted medical use; they cannot be prescribed or dispensed by pharmacists under federal law.
Emergency oral Schedule II
In an emergency, a prescriber may phone in a Schedule II prescription; the pharmacist may dispense it if a written prescription arrives within 7 days.
DEA Form 222
Form used to order Schedule I and II controlled substances; it must be completed accurately, and records of distributions must be retained for inspection.
FDA labeling requirements
Prescription drugs must bear FDA-approved labeling with adequate directions for use; pharmacists must dispense with required labeling and auxiliary information.
Poison Prevention Packaging
Federal law requires child-resistant packaging for most prescription drugs unless the patient requests otherwise or the prescriber directs noncomplying packaging.
Refill authorization
A pharmacist may dispense refills only as authorized by the prescriber; unauthorized refills or extensions violate federal and state law.
Reporting theft or loss
Pharmacies must notify DEA in writing of theft or significant loss within one business day and complete a DEA Form 106 describing the circumstances.